Article History
Received: 6 December 2019
Accepted: 19 February 2020
First Online: 10 March 2020
Compliance with ethical standards
:
: LP received consultancy fees from Air Liquide MS, Faron, and MSD. CEL received fees from Bayer Healthcare in relationship with the current work (advisory board on inhaled amikacin), and fees from Merck, ThermoFischer Brahms, Biomérieux, Carmat, and Faron outside the current work. MK has received royalties from UpToDate Inc. for articles on ventilator-associated pneumonia.
Free to read: This content has been made available to all.